KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Non-Current Assets: 2009-2025

Historic Non-Current Assets for Charles River Laboratories International (CRL) over the last 17 years, with Sep 2025 value amounting to $6.0 billion.

  • Charles River Laboratories International's Non-Current Assets fell 8.10% to $6.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $6.0 billion, marking a year-over-year decrease of 8.10%. This contributed to the annual value of $6.1 billion for FY2024, which is 7.00% down from last year.
  • Per Charles River Laboratories International's latest filing, its Non-Current Assets stood at $6.0 billion for Q3 2025, which was down 1.79% from $6.1 billion recorded in Q2 2025.
  • Over the past 5 years, Charles River Laboratories International's Non-Current Assets peaked at $6.6 billion during Q4 2023, and registered a low of $4.4 billion during Q1 2021.
  • For the 3-year period, Charles River Laboratories International's Non-Current Assets averaged around $6.3 billion, with its median value being $6.3 billion (2023).
  • Its Non-Current Assets has fluctuated over the past 5 years, first surged by 39.44% in 2021, then decreased by 8.10% in 2025.
  • Quarterly analysis of 5 years shows Charles River Laboratories International's Non-Current Assets stood at $5.8 billion in 2021, then grew by 7.19% to $6.2 billion in 2022, then increased by 6.86% to $6.6 billion in 2023, then fell by 7.00% to $6.1 billion in 2024, then dropped by 8.10% to $6.0 billion in 2025.
  • Its Non-Current Assets stands at $6.0 billion for Q3 2025, versus $6.1 billion for Q2 2025 and $6.1 billion for Q1 2025.